HopeStage
Back to all studies
Recruitment unclearEUCTR 2012-001779-35

The effects of pregabalin augmentation of antidepressant drug on neuro-cognitive functioning in patients with generalized anxiety disorder

This historical record does not confirm current site availability.

Historical research recordUnited Kingdom
The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Who could participate?

This study is for people with anxiety. Other eligibility criteria apply.

Listed locations
United Kingdom
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruitment unclear
Enrollment listed in the registry
Not clearly listed
Sponsor
University of Southampton
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United Kingdom
Age range
Not clearly listed
Official registry ID
EUCTR 2012-001779-35
Official title
Show the full official title

The effects of pregabalin augmentation of antidepressant drug on neuro-cognitive functioning in patients with generalized anxiety disorder

Recruitment & locations

Status unknown

United Kingdom

Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Southampton, a university.

Who can participate?

This study is for people with anxiety. Other eligibility criteria apply.

Want to explore more studies?

Explore studies